Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 377.95
-9.10 (-2.35%)
At close: Jan 8, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 504.36 billion as of January 8, 2026. Its market cap has increased by 20.29% in one year.
Market Cap
504.36B
Enterprise Value
671.20B
Revenue
164.76B
Ranking
n/a
PE Ratio
96.77
Stock Price
377.95
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 504.36B, an increase of 1,010.61%. That is a compound annual growth rate of 11.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 516.50B | -1.74% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.22T |
| Divi's Laboratories | 1.75T |
| Cipla | 1.18T |
| Apollo Hospitals Enterprise | 1.06T |
| Mankind Pharma | 933.43B |
| Zydus Lifesciences | 913.21B |
| Aurobindo Pharma | 700.50B |
| Alkem Laboratories | 692.64B |